[EN] ANTIVIRAL PHOSPHODIAMIDE COMPOUNDS<br/>[FR] COMPOSÉS ANTIVIRAUX DE PHOSPHODIAMIDE
申请人:MERCK SHARP & DOHME
公开号:WO2017007701A1
公开(公告)日:2017-01-12
Compounds of Formula (I): and their pharmaceutically acceptable salts are useful for the inhibition of HIV reverse transcriptase. The compounds may also be useful for the prophylaxis or treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antiviral agents, immunomodulators, antibiotics or vaccines.
Compounds of Formula I and pharmaceutically acceptable salts and co-crystals thereof are useful for the inhibition of HIV reverse transcriptase. The compounds may also be useful for the prophylaxis or treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antiviral agents, immunomodulators, antibiotics or vaccines.
式 I 的化合物及其药学上可接受的盐类和共晶体可用于抑制 HIV 逆转录酶。这些化合物还可用于预防或治疗艾滋病病毒感染,以及预防、延缓艾滋病的发生、发展和治疗。这些化合物及其盐类可用作药物组合物的成分,也可与其他抗病毒剂、免疫调节剂、抗生素或疫苗结合使用。
Synthetic sweeteners. 3. Aspartyl dipeptide esters from L- and D-alkylglycines
作者:Robert H. Mazur、Judith A. Reuter、Kenneth A. Swiatek、James M. Schlatter